Home

Luca Benatti

CIK 1613842 · last filed 2025-12-29

Luca Benatti is a corporate insider who has filed 19 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for QNCX, was dated Dec 29, 2025. Across all open-market trades the lifetime net is +$38.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.8K

Companies

2

Total Filings

19

Lifetime Open-Market Net

$38.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QNCX Director 196 $19.37 $3.8K -$173.5K 5 2025-12-29
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Director 33,598 $19.00 $638.4K $212.1K 12 2023-05-25

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-29 QNCX Notice (144) −50,000 -$173.2K EDGAR
2025-12-29 QNCX Sell (S) −50,000 -$173.5K EDGAR
2025-12-29 QNCX Other (J) +8,918 $0 EDGAR
2025-06-06 QNCX Grant (A) — $0 EDGAR
2024-06-07 QNCX Grant (A) — $0 EDGAR
2023-11-13 — Mixed −33,598 -$638.4K
2023-10-24 QNCX Grant (A) — $0 EDGAR
2023-05-25 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +8,111 $0 EDGAR
2022-05-27 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +7,737 $0 EDGAR
2021-06-01 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +7,029 $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.